Form D — GelSana Therapeutics, Inc.
0002002665-26-000004 · filed Oct 8, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,931,726
- Total sold
- $4,352,701
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GelSana Therapeutics, Inc.
- CIK
- 2002665
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 12635 E MONTVIEW BLVD STE 326
AURORA, CO 80045 - Phone
- (216) 502-0901
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Melissa Krebs · Executive OfficerAurora, CO Find on LinkedIn ↗
-
Mike Freeman · DirectorAurora, CO Find on LinkedIn ↗
-
Diana Verrilli · DirectorAurora, CO Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗